APA (7th ed.) Citation

Surjan, J., Grossi, J. D., Del Porto, J. A., Delfino, R. S., de Oliveira Cerqueira, R., Lucchese, A. C., . . . Lacerda, A. L. T. (2022). Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression. Clinical drug investigation, 42(10), 865-873. https://doi.org/10.1007/s40261-022-01193-z

Chicago Style (17th ed.) Citation

Surjan, Juliana, et al. "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression." Clinical Drug Investigation 42, no. 10 (2022): 865-873. https://doi.org/10.1007/s40261-022-01193-z.

MLA (9th ed.) Citation

Surjan, Juliana, et al. "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression." Clinical Drug Investigation, vol. 42, no. 10, 2022, pp. 865-873, https://doi.org/10.1007/s40261-022-01193-z.